Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lucira Health Inc (NQ: LHDX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lucira Health Inc

< Previous 1 2 3 4 5 6 7 Next >
Mid-Afternoon Market Update: Dow Dips 500 Points; Ra Medical Systems Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded down 1.47% to 33,769 while the NASDAQ fell 2.21% to 13,093.66. The S&P also fell, dropping 1.66% to 4,083.31. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today
Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers... 
Via Benzinga
MedTech Round Up: Update On Lucira Health, Second Sight Medical ClearPoint Neuro, Medtronic, Sientra
Lucira Health Inc (NASDAQ: LHDX) has announced that its Lucira Check IT COVID-19 test kit is now available on Amazon.com in the US. Each Lucira Check IT test... 
Via Benzinga
Exposures COVID-19
Mid-Day Market Update: Array Technologies Drops Following Downbeat Earnings; Harrow Health Shares Climb
Midway through trading Wednesday, the Dow traded down 0.79% to 33,998.86 while the NASDAQ fell 1.59% to 13,177.20. The S&P also fell, dropping 1.03% to 4,109.52. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 76% to $5.84 after the company reported better-than-expected Q1 results. Lucira Health, Inc. (NASDAQ: LHDX) gained... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; US Consumer Prices Rise In April
Following the market opening Wednesday, the Dow traded down 0.60% to 34,064.63 while the NASDAQ fell 1.50% to 13,188.30. The S&P also fell, dropping 0.86% to 4,116.41. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
LUCIRA™ CHECK IT COVID-19 Self-Test Now Available on Amazon
From Lucira Health, Inc.
Via Business Wire
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021
Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,... 
Via Benzinga
Is Lucira Health a Buy?
This coronavirus testing stock has taken shareholders on a roller-coaster ride since its IPO. 
Via The Motley Fool
Exposures COVID-19
Lucira Health Celebrates Grand Opening of New Jabil Manufacturing Plant, Increasing Production of LUCIRA CHECK IT™ COVID-19 Self-Test
From Lucira Health, Inc.
Via Business Wire
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Health Canada Authorizes First COVID-19 Test For Self-Testing At Home
From Lucira Health, Inc.
Via Business Wire
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debuts in San Francisco Bay Area this Friday with LUCIRA™ Check It COVID-19 At-Home Test
From Lucira Health, Inc.
Via Business Wire
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers INmune Bio (NASDAQ:INMB) stock rose 26.18% to $13.59 during Monday's regular session. As of 08:06 EST, this security is trading at a volume of 560.6K shares,... 
Via Benzinga
54 Biggest Movers From Friday
Gainers Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares surged 73.9% to close at $31.30 on Friday after the company priced its IPO at $18 per share. General Finance... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.22% to 33,669.76 while the NASDAQ rose 0.80% to 13,960.92. The S&P also rose, gaining 0.28% to 4,139.55. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
50 Biggest Movers From Yesterday
Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution... 
Via Benzinga
Why Lucira Health Stock Is Plunging Today
This analyst thinks the company's stock performance will trail that of the market. 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for NovoCure's stock is 11.4 million as of 12:32 EST... 
Via Benzinga
Mid-Day Market Update: Nasdaq Jumps 100 Points; Avenue Therapeutics Shares Slide
Midway through trading Tuesday, the Dow traded down 0.34% to 33,630.52 while the NASDAQ rose 0.75% to 13,953.54. The S&P also rose, gaining 0.12% to 4,133.03. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers Mackinac Financial Corporation (NASDAQ: MFNC) jumped 57.6% to $20.75 after the company, and Nicolet Bankshares, jointly announced the execution of a definitive merger... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Fastenal Profit Tops Estimates
Following the market opening Tuesday, the Dow traded down 0.39% to 33,615.29 while the NASDAQ rose 0.70% to 13,946.14. The S&P also rose, gaining 0.11% to 4,132.39. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.